Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Therapeutic advantages of paricalcitol further defined

Jan. 25, 1999

Rochester Medical files PMA for FemSoft

Jan. 22, 1999

Improved treatments for BPH in development at Pfizer

Jan. 22, 1999

SNAP-5540: a uroselective adrenergic BPH agent

Jan. 20, 1999

Ortho-McNeil reports new treatments for BPH

Jan. 20, 1999

Lilly's new 5-HT1D agonists claimed for CNS and bladder disorders

Jan. 4, 1999

OPC-31260: potential utility in cirrhosis patients with impaired water handling

Dec. 30, 1998

Tobishi's pollen extract improves bladder dysfunction, nonbacterial prostatitis in rats

Dec. 21, 1998

FDA clears first and only once-daily treatment for overactive bladder

Dec. 21, 1998

New agents for micturition disorders discovered at Kyowa Hakko

Dec. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...